TC BIOPHARM HOLDINGS PLC's ticker is and the CUSIP is 87807D111. A total of 6 filers reported holding TC BIOPHARM HOLDINGS PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $393 | -51.4% | 18,823 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $809 | -57.0% | 18,823 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,880 | +11.6% | 18,823 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1,684 | -98.6% | 18,823 | -98.0% | 0.00% | -97.7% |
| Q3 2022 | $118,000 | -47.1% | 941,176 | 0.0% | 0.04% | -51.7% |
| Q2 2022 | $223,000 | -51.6% | 941,176 | 0.0% | 0.09% | -42.2% |
| Q1 2022 | $461,000 | – | 941,176 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kepos Capital LP | 470,588 | $10 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| Nantahala Capital Management | 235,294 | $5,176 | 0.00% |
| Altium Capital Management LP | 18,823 | $393 | 0.00% |
| ARMISTICE CAPITAL, LLC | 37,647 | $787 | 0.00% |
| UBS Group AG | 106 | $1 | 0.00% |